Open-Label Absorption, Distribution, Metabolism, Excretion (ADME) and Pharmacokinetics (PK) Following a Single Oral Dose of AZD1236 in Healthy Male Subjects

NCT01007929 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
4
Enrollment
INDUSTRY
Sponsor class

Stopped Future development of AZD1236 is currently under review by the project team and no new studies will be started until this review is completed.

Conditions

Interventions

Sponsor

AstraZeneca